Global Psoriasis Therapeutics Market 2015-2019

1
Global Psoriasis Therapeutics Market 2015-2019
2
DESCRIPTION
About Psoriasis and Its Types Psoriasis is a
common immune-mediated disease of the skin. In
psoriasis, the skin grows fast and causes buildup
of thick white, red, or silvery patches of skin.
It alters the normal cell cycle of the skin. The
new cells of the skin grow and move quickly to
the surface of the skin to form patches known as
"plaques". The plaques are commonly found on
knees, elbows, scalp, hands, and feet. Psoriasis
occurs mostly in adults, but can also be seen in
children and adolescents. The etiology of the
disease is unknown, however, it is believed to be
an immune-mediated process. It is believed that
the over-activity of the immune system can cause
inflammation, thereby resulting in flaking of the
skin.   The Global Psoriasis Therapeutics market
to grow at a CAGR of 9.95 percent over the period
2014-2019.   Read more details at
http//www.bigmarketresearch.com/global-psoriasis-
therapeutics-2015-2019-market  
3
REPORT OVERVIEW
Covered in this Report  This report covers the
present scenario and the growth prospects of the
Global Psoriasis Therapeutics market for the
period 2015-2019. To calculate the market size,
the report considers revenue generated from the
sales of various drugs including systemic and
topical drugs used in the treatment of
Psoriasis Psoriatic Arthritis   The Global
Psoriasis Therapeutics market is segmented based
on the mechanism of action of the drugs used to
treat psoriasis and psoriatic arthritis as
illustrated below TNF Inhibitors PDE4
Inhibitors Interleukin Blockers Others   On
the basis of route of administration adopted for
the treatment of psoriasis, the Global Psoriasis
Therapeutics market is segmented as follows
Oral Parenteral Topical
4
REPORT OVERVIEW
The report also presents the vendor landscape and
a corresponding detailed analysis of the top four
vendors in the Global Psoriasis Therapeutics
market. The vendor landscape section includes a
market share analysis of the major vendors along
with the competitive performances of their
product portfolios. In addition, it discusses the
major drivers that influence the growth of the
market. It also outlines the challenges faced by
the vendors and the market at large, as well as
the key trends that are emerging in the market.
In addition, late-stage pipeline molecules
developed for the treatment of psoriasis have
been discussed. Global Psoriasis Therapeutics
Market 2015-2019, has been prepared based on an
in-depth market analysis with inputs from
industry experts. The report covers the Americas,
the APAC and the EMEA regions it also covers the
Global Psoriasis Therapeutics market landscape
and its growth prospects in the coming years. The
report also includes a discussion of the key
vendors operating in this market.
5
KEY REGIONS
Key Regions Americas APAC EMEA
 Key Vendors Abbvie Amgen Janssen
Pharmaceuticals Pfizer  Other Prominent
Vendors AbGenomics Almirall Anacor
Pharmaceuticals ApoPharma Astellas Pharma
AstraZeneca Aurinia Pharmaceuticals Biocon
Biogen Idec Biotest
6
KEY AUDIENCES
Market Driver Growing Unmet Needs For a full,
detailed list, view our report   Market
Challenge Unknown Disease Etiology For a
full, detailed list, view our report   Market
Trend Market Dominance by Biologics For a
full, detailed list, view our report
7
KEY AUDIENCES
Key Questions Answered in this Report What will
the market size be in 2019 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors?   Enquire about report
http//www.bigmarketresearch.com/report-enquiry/16
9886
8
Get Full Information At
http//www.bigmarketresearch.com/global-psoriasis-
therapeutics-2015-2019-market